We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.15 | 2.27% | 6.75 | 6.02 | 7.48 | - | 316,825 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.75 | 13.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/3/2020 08:26 | SNG Near term high probability potential newsflow is 1. Early NHS Trial feedback 2. Roll-out to other countries 3. Rollout to additional UK NHS patients 4. An update on collaboration with Astra Zeneca. Wildcard if it gets mentioned on mainstream media or by Boris during his daily updates | saw89 | |
25/3/2020 08:26 | A rather big TR1, a large reduction for someone | tickboo | |
25/3/2020 08:26 | RNS Just released on major shareholdings | makendon | |
25/3/2020 08:24 | Hazl, thank you for your gfin tip, just watch the spread, currently at 12.5% | makendon | |
25/3/2020 08:23 | London and Madrid are now facing WORSE coronavirus outbreaks than Italy's worst-hit region of Lombardy with deaths doubling every TWO days - but New York's mortality rate is outpacing them all - as global fatalities hit 18,574hTTps://www.da | tidy 2 | |
25/3/2020 08:17 | NCYT peaked at an Mcap of £150m for some £4 test kits. This is a TREATMENT undergoing NHS trials with covid-19 patients as we speak. Current Mcap ~£50m. Blue sky potential | saw89 | |
25/3/2020 08:08 | GFIN has seen brilliant news this week as well...the F1 news in particular. Like your share Nobby it hadn't done the biz; but is strangely coming into its own now. But to reiterate I still think these are very risky markets. | hazl | |
25/3/2020 07:57 | This is a fast moving company ,at the moment so I expect news to be on going. | hazl | |
25/3/2020 07:41 | FARN also has a promising anti cancer drug so you would expect a differential. Of course SNG also have the fibrosis inhibitor which definitely does have a value but not as much as the cancer drug. But yes 5 xs higher is too much of a difference. | nobbygnome | |
25/3/2020 07:37 | Just a reminder: FARN Mcap trading 5x higher than SNG. SNG have a superior delivery method, NHS trials with 100 patients active now, and Astra Zeneca on the scene. Value gap has to close as NHS trial progresses and we get signs of positive impact (biggest clue being wider roll-out to more patients). Don’t be surprised if USA start taking interest in this. | saw89 | |
25/3/2020 07:35 | Parliament to close this evening - following the passing of emergency legislation. | 801710245 | |
25/3/2020 07:27 | Of the 427 confirmed imported cases reported on March 23, 380 are Chinese and the rest 47 are foreign nationals.Also on Tuesday, four deaths and 33 new suspected cases were reported on the mainland with thr | tidy 2 | |
25/3/2020 07:23 | hTTps://www.google.c | tidy 2 | |
25/3/2020 07:21 | 47 new Chinese cases? - Is that on the BBC? Donald Trump continues to 'take the buscuit' - "Easter is a very special time (tremendous), I don't want to see any 'lockdowns' (very bad) still in place by Easter..." I'm paraphrasing slightly, but that's essentially what he said on the radio just now - completely at odds with what state governors are saying about the virus spreading like a bullet train. What a prune. | 801710245 | |
25/3/2020 07:15 | Brilliant news at Novacyt should add to the momentum here today and a fantastic day for both companies as money flows into SNG. | likya123 | |
25/3/2020 07:13 | 47 new COVID19 cases in China apparently. Morning all. | tidy 2 | |
25/3/2020 06:56 | I just looked at my accounts and am somewhat astonished to see I bought another 30k yesterday. My little bit of luck over at DEMG facilitated those purchases but that was more than I thought. I am losing it.... | nobbygnome | |
25/3/2020 06:55 | You guys are getting a little exuberant. This is supposed to be the calm and considered thread. Please watch yourselves... I very much doubt anything has leaked. People are just beginning to see the true potential here and that realisation will continue to grow! | nobbygnome | |
25/3/2020 06:50 | Morning, as I said yesterday there was very significant buying, not punting, especially yesterday. It is obvious to me that positive news has already leaked and this will be confirmed by todays price action regardless of a RNS. I'm expecting very significant movements north in the next few trading hours. Interestingly the company would not be able to keep it a secret that early success in the trials has led to extension of trials to other hospitals, this would either be RNSd and/or all over the media. If no RNS at 7am today I think last chance to get in below a quid! | likya123 | |
25/3/2020 06:45 | And it’s a very high probability... Phase II clinical trials in asthmatic patients have shown that SNG001 is well tolerated, enhances the lungs’ antiviral defences and improves lung function during cold or flu infection. | saw89 | |
25/3/2020 06:43 | This is the best bit: Positive initial results from the 100 patient pilot phase could see the trial expanded to more hospitals | saw89 | |
25/3/2020 06:37 | During the study, patients at the University Hospital Southampton and up to 10 other National Health Service (NHS) hospitals will receive the best current COVID-19 care while inhaling either SNG001 or a placebo over 14 days. They stated that positive initial results from the 100 patient pilot phase could see the trial expanded to more hospitals. Professor Wilkinson stated that: “Having the trial adopted by the NIHR Respiratory Translational Research Collaboration is key to taking any positive findings forward as part of their efforts to accelerate discovery and development for COVID-19 and I am indebted to the support my collaborators are giving to get this study started.” Phase II clinical trials in asthmatic patients have shown that SNG001 is well tolerated, enhances the lungs’ antiviral defences and improves lung function during cold or flu infection. | saw89 | |
25/3/2020 06:35 | Another bit of coverage, well written | saw89 | |
25/3/2020 06:35 | www.europeanpharmace | saw89 | |
25/3/2020 06:10 | Not that it's necessarily going to be a factor for SNG, but the Dow Jones had its largest single day percentage rise yesterday, since 1933. | 801710245 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions